NEW ACTIVE PHARMACEUTICAL INGREDIENTS FUNDAMENTALS EXPLAINED

“The existing situation has exposed some structural weaknesses from the EU’s medicines supply chain plus a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides mentioned. She advised that supply chain concerns be resolved in an EU pharmaceutical technique predicted being launched by the top